Eupraxia Pharmaceuticals Announces CFO Succession Plan
February 19, 2025
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, announced that it has appointed Alex Rothwell as the Company’s new Chief Financial Officer, effective immediately. Bruce Cousins, the Company’s